{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:21:03Z","timestamp":1787530863293,"version":"build-2736575974"},"update-to":[{"DOI":"10.1002\/14651858.cd003167.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2007,10,17]],"date-time":"2007-10-17T00:00:00Z","timestamp":1192579200000}}],"reference-count":76,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003167.pub3","type":"journal-article","created":{"date-parts":[[2007,10,10]],"date-time":"2007-10-10T12:19:30Z","timestamp":1192018770000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Medical interventions for primary open angle glaucoma and ocular hypertension"],"prefix":"10.1002","volume":"2009","author":[{"given":"Clemens","family":"Vass","sequence":"first","affiliation":[{"name":"Medical University of Vienna; Department of Ophthalmology; W\u00e4hringer G\u00fcrtel 18-20 Vienna Austria A-1090"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Hirn","sequence":"additional","affiliation":[{"name":"Medical University of Vienna; Department of Ophthalmology; W\u00e4hringer G\u00fcrtel 18-20 Vienna Austria A-1090"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Sycha","sequence":"additional","affiliation":[{"name":"Medical University of Vienna; Department of Neurology; W\u00e4hringer G\u00fcrtel 18-20 Vienna Austria A-1090"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Findl","sequence":"additional","affiliation":[{"name":"Medical University of Vienna; Department of Ophthalmology; W\u00e4hringer G\u00fcrtel 18-20 Vienna Austria A-1090"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Sacu","sequence":"additional","affiliation":[{"name":"Medical University of Vienna; Department of Ophthalmology; W\u00e4hringer G\u00fcrtel 18-20 Vienna Austria A-1090"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bauer","sequence":"additional","affiliation":[{"name":"Medical University of Vienna; Institute of Medical Statistics; Spitalgasse23 Vienna Austria A-1090"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leopold","family":"Schmetterer","sequence":"additional","affiliation":[{"name":"Medical University of Vienna; Institute of Medical Physics, Department of Clinical Pharmacology; W\u00e4hringer G\u00fcrtel 18-20 Vienna Austria A-1090"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,10,17]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD003167.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0161-6420(88)33205-7","article-title":"A clinical trial of timolol and epinephrine in the treatment of primary open-angle glaucoma","volume":"95","author":"Alexander","year":"1988","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD003167.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/02713689209069161","article-title":"Long-term effect of ophthalmic beta-adrenoceptor antagonists on intraocular pressure and retinal sensitivity in primary open-angle glaucoma","volume":"11","author":"Collignon-Brach","year":"1992","journal-title":"Current Eye Research"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003167.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1016\/0039-6257(94)90059-0","article-title":"Longterm effect of topical beta-blockers on intraocular pressure and visual field sensitivity in ocular hypertension and chronic open-angle glaucoma","volume":"38","author":"Collignon-Brach","year":"1994","journal-title":"Survey of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD003167.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00061198-199808000-00006","article-title":"A comparison of the effects of betaxolol, timolol, and pilocarpine on visual function in patients with open-angle glaucoma","volume":"7","author":"Drance","year":"1998","journal-title":"Journal of Glaucoma"},{"issue":"9","key":"10.1002\/14651858.CD003167.pub3-BIB0006|cit5","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/S0161-6420(02)01167-3","article-title":"The European glaucoma prevention study design and baseline description of the participants","volume":"109","author":"The European Glaucoma Prevention Study","year":"2002","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD003167.pub3-BIB0005|cit6","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ophtha.2004.11.030","article-title":"Results of the European glaucoma prevention study","volume":"112","author":"The European Glaucoma Prevention Study Group","year":"2005","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD003167.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S0161-6420(89)32688-1","article-title":"A long-term clinical trial of timolol versus no treatment in the management of glaucoma suspects","volume":"96","author":"Epstein","year":"1989","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD003167.pub3-BIB0008|cit8","first-page":"317","article-title":"Comparison of the ocular effects of three beta-blockers: timolol, carteolol, and betaxolol","volume":"28","author":"Fama","year":"1996","journal-title":"Annals of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD003167.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/112067219200200402","article-title":"Influence of carteolol and timolol on IOP and visual fields in glaucoma: a multi-center, double-masked, prospective study","volume":"2","author":"Flammer","year":"1992","journal-title":"European Journal of Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD003167.pub3-BIB0010|cit10","first-page":"289","article-title":"Leovbunolol compared with timolol for the control of elevated intraocular pressure","volume":"18","author":"Geyer","year":"1986","journal-title":"Annals of Ophthalmology"},{"issue":"12","key":"10.1002\/14651858.CD003167.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1136\/bjo.72.12.892","article-title":"Levobunolol compared with timolol: a four-year study","volume":"72","author":"Geyer","year":"1988","journal-title":"British Journal of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD003167.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/01.ijg.0000151683.04410.f3","article-title":"A long-term prospective study of risk factors for glaucomatous visual field loss in patients with ocular hypertension","volume":"14","author":"Bengtsson","year":"2005","journal-title":"Journal of Glaucoma"},{"issue":"6","key":"10.1002\/14651858.CD003167.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00417-004-1103-8","article-title":"Diurnal IOP fluctuation: Not an independent risk factor for glaucomatous visual field loss in high-risk ocular hypertension","volume":"243","author":"Bengtsson","year":"2005","journal-title":"Graefe's Archive for Clinical & Experimental Ophthalmology"},{"issue":"11","key":"10.1002\/14651858.CD003167.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s004170000189","article-title":"Long-term effects of timolol therapy in ocular hypertension: a double-masked, randomised trial","volume":"238","author":"Heijl","year":"2000","journal-title":"Graefe's Archive for Clinical and Experimental Ophthalmology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003167.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"S156","DOI":"10.1016\/0039-6257(94)90060-4","article-title":"Longterm visual field follow-up of glaucoma patients treated with beta-blockers","volume":"38","author":"Kaiser","year":"1994","journal-title":"Survey of Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD003167.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s00417-002-0614-4","article-title":"Results of the betaxolol versus placebo treatment trial in ocular hypertension","volume":"241","author":"Kamal","year":"2003","journal-title":"Graefes Archive for Clinical & Experimental Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD003167.pub3-BIB0018|cit17","first-page":"5","article-title":"Five-year follow-up study of timolol in patients at moderate risk of developing open-angle glaucoma","volume":"7","author":"Kass","year":"1990","journal-title":"Chibret International Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD003167.pub3-BIB0019|cit18","first-page":"598","article-title":"Timolol treatment prevents or delays glaucomatous visual field loss in individuals with ocular hypertension: A five-year, randomized, double-masked, clinical trial","volume":"87","author":"Kass","year":"1989","journal-title":"Transactions of the American Ophthalmological Society"},{"issue":"11","key":"10.1002\/14651858.CD003167.pub3-BIB0017|cit19","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1001\/archopht.1989.01070020668025","article-title":"Topical timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals. A randomized, double-masked, long-term clinical trial","volume":"107","author":"Kass","year":"1989","journal-title":"Archives of Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD003167.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archopht.120.6.701","article-title":"The ocular hypertension treatments study: a randomized trial determines that topical hypotensive medication delays or prevents the onset of primary open-angle glaucoma","volume":"120","author":"Kass","year":"2002","journal-title":"Archives of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD003167.pub3-BIB0021|cit21","first-page":"14","article-title":"The effect of timolol on topographic features of the optic disk in ocular hypertension","volume":"7","author":"Kitazawa","year":"1990","journal-title":"Chibret International Journal of Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD003167.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/S0161-6420(98)91048-X","article-title":"Twelve-month results of an ongoing randomized trial comparing brimonidine tartrate 0.2% and timolol 0.5% given twice daily in patients with glaucoma or ocular hypertension","volume":"105","author":"Leblanc","year":"1998","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD003167.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0149-2918(00)87981-3","article-title":"Ongoing clinical assessment of the safety profile and efficacy of brimonidine compared with timolol: year-three results","volume":"22","author":"Melamed","year":"2000","journal-title":"Clinical Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD003167.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/archopht.1985.01050030075025","article-title":"Levobunolol compared with timolol for the long-term control of elevated intraocular pressure","volume":"103","author":"Berson","year":"1985","journal-title":"Archives of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD003167.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0002-9394(14)75859-3","article-title":"Levobunolol vs timolol for open-angle glaucoma and ocular hypertension","volume":"99","author":"Cinotti","year":"1985","journal-title":"American Journal of Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD003167.pub3-BIB0026|cit26","first-page":"1271","article-title":"Levobunolol. A beta-adrenoceptor antagonist effective in the long-term treatment of glaucoma","volume":"92","author":"Novack","year":"1985","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD003167.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0161-6420(89)32851-X","article-title":"Levobunolol: a four-year study of efficacy and safety in glaucoma treatment","volume":"96","author":"Novack","year":"1989","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD003167.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1136\/bjo.69.8.593","article-title":"Long-term ocular hypotensive effect of levobunolol: results of a one-year study","volume":"69","author":"Ober","year":"1985","journal-title":"British Journal of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD003167.pub3-BIB0029|cit29","first-page":"97","article-title":"Ocular hypertension: a follow-up study in treated and untreated patients","volume":"9","author":"Ravalico","year":"1994","journal-title":"New Trends in Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD003167.pub3-BIB0030|cit30","first-page":"1478","article-title":"The effect of long-term intraocular pressure reduction on the differential light sensitivity in glaucoma suspects","volume":"29","author":"Chauhan","year":"1988","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"3","key":"10.1002\/14651858.CD003167.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0161-6420(91)32296-6","article-title":"A comparison of treated and untreated glaucoma suspects","volume":"98","author":"Schulzer","year":"1991","journal-title":"Ophthalmology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003167.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/S0039-6257(96)82029-7","article-title":"Clinical experience with brimonidine 0.2% and timolol 0.5% in glaucoma and ocular hypertension","volume":"41","author":"Schuman","year":"1996","journal-title":"Survey of Ophthalmology"},{"issue":"7","key":"10.1002\/14651858.CD003167.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/archopht.1997.01100160017002","article-title":"A 1-year study of brimonidine twice daily in glaucoma and ocular hypertension. A controlled, randomized, multicenter clinical trial","volume":"115","author":"Schuman","year":"1997","journal-title":"Archives of Ophthalmology"},{"issue":"Suppl 215","key":"10.1002\/14651858.CD003167.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-0420.1995.tb00588.x","article-title":"Decrease of optic disc cupping and pallor of ocular hypertensives with timolol therapy","volume":"73","author":"Schwartz","year":"1995","journal-title":"Acta Ophthalmologica Scandinavica"},{"issue":"Suppl 215","key":"10.1002\/14651858.CD003167.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1600-0420.1995.tb00589.x","article-title":"Increase of retinal nerve fiber thickness in ocular hypertensives with timolol therapy","volume":"73","author":"Schwartz","year":"1995","journal-title":"Acta Ophthalmologica Scandinavica"},{"issue":"Pt 3","key":"10.1002\/14651858.CD003167.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/eye.1988.49","article-title":"A comparative evaluation of timolol maleate and pilocarpine in the treatment of chronic open angle glaucoma","volume":"2","author":"Dallas","year":"1988","journal-title":"Eye"},{"issue":"3","key":"10.1002\/14651858.CD003167.pub3-BIB0037|cit37","first-page":"50","article-title":"Timolol vs pilocarpine in open angle glaucoma: the observation of significant differences in visual field response in patients with clinically equivalent IOP control","volume":"5","author":"Sponsel","year":"1987","journal-title":"Chibret International Journal of Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD003167.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1089\/jop.2005.21.475","article-title":"Comparison of the effects of brimonidine 0.2% and timolol 0.5% on retinal nerve fiber layer thickness in ocular hypertensive patients: A prospective, unmasked study","volume":"21","author":"Tsai","year":"2005","journal-title":"Journal of Ocular Pharmacology and Therapeutics"},{"issue":"10","key":"10.1002\/14651858.CD003167.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0161-6420(92)31773-7","article-title":"Effect of timolol versus pilocarpine on visual field progression in patients with primary open-angle glaucoma","volume":"99","author":"Vogel","year":"1992","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD003167.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1136\/bjo.85.8.962","article-title":"A 7-year prospective comparative study of three topical beta-blockers in the management of primary open angle glaucoma","volume":"85","author":"Watson","year":"2001","journal-title":"British Journal of Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD003167.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/00132578-200207000-00014","article-title":"A 7-year prospective comparative study of three topical beta blockers in the management of primary open angle glaucoma","volume":"3","author":"Watson","year":"2002","journal-title":"Evidence Based Eye Care"},{"issue":"Pt 3","key":"10.1002\/14651858.CD003167.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/eye.1992.48","article-title":"Ocular hypertension: correlation of anterior chamber angle width and risk of progression to glaucoma","volume":"6","author":"Wishart","year":"1992","journal-title":"Eye"},{"issue":"2","key":"10.1002\/14651858.CD003167.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0021-5155(02)00665-2","article-title":"Influence of topical betaxolol and timolol on visual field in Japanese open-angle glaucoma patients","volume":"47","author":"Araie","year":"2003","journal-title":"Japanese Journal of Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD003167.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","article-title":"Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial","volume":"120","author":"Heijl","year":"2002","journal-title":"Archives of Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD003167.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.ophtha.2005.03.028","article-title":"Treatment and vision-related quality of life in early manifest glaucoma trial","volume":"112","author":"Hyman","year":"2005","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1002\/14651858.CD003167.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/S0161-6420(99)90497-9","article-title":"Early manifest glaucoma trial. Design and baseline data","volume":"106","author":"Leske","year":"1999","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD003167.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/00055735-200404000-00008","article-title":"Factors for progression and glaucoma treatment: the Early Manifest Glaucoma Trial","volume":"15","author":"Leske","year":"2004","journal-title":"Current Opinion in Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD003167.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1755-3768.1988.tb04006.x","article-title":"Treatment versus no treatment in chronic open angle glaucoma","volume":"66","author":"Holmin","year":"1988","journal-title":"Acta Ophthalmologica"},{"issue":"2","key":"10.1002\/14651858.CD003167.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s004170050202","article-title":"The favorable effect of topical betaxolol and timolol on glaucomatous visual fields: a 2-year follow-up study","volume":"237","author":"Vainio Jylha","year":"1999","journal-title":"Graefes Archive for Clinical & Experimental Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD003167.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1034\/j.1600-0420.2002.800507.x","article-title":"Progression of retinal nerve fibre layer damage in betaxolol- and timolol-treated glaucoma patients","volume":"80","author":"Vainio-Jylh\u00e4","year":"2002","journal-title":"Acta Ophthalmologica Scandinavica"},{"issue":"5","key":"10.1002\/14651858.CD003167.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0008-4182(06)80025-6","article-title":"Canadian Glaucoma Study: 1. Study design, baseline characteristics, and preliminary analyses","volume":"41","author":"Canadian Glaucoma Study Group","year":"2006","journal-title":"Canadian Journal of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD003167.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/112067210701700108","article-title":"A double-masked, randomized, parallel comparison of a fixed combination of bimatoprost 0.03% timolol 0.5% with non-fixed combination use in patients with glaucoma or ocular hypertension","volume":"17","author":"Hommer","year":"2007","journal-title":"European Journal of Ophthalmology"},{"issue":"11","key":"10.1002\/14651858.CD003167.pub3-BIB0053|cit53","first-page":"729","article-title":"Phase III long-term study and comparative clinical study of nipradilol ophthalmic solution in patients with primary open-angle glaucoma and ocular hypertension","volume":"56","author":"Kanno","year":"2006","journal-title":"Arzneimittel-Forschung"},{"issue":"12","key":"10.1002\/14651858.CD003167.pub3-BIB0054|cit54","first-page":"820","article-title":"Phase III long-term study and comparative clinical study of nipradilol ophthalmic solution in patients with primary open-angle glaucoma and ocular hypertension. Part 2","volume":"56","author":"Kanno","year":"2006","journal-title":"Arzneimittel-Forschung"},{"issue":"2","key":"10.1002\/14651858.CD003167.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1358\/dot.2007.43.2.1032058","article-title":"Travoprost 0.004% imolol 0.5% fixed combination","volume":"43","author":"Noecker","year":"2007","journal-title":"Drugs of Today"},{"issue":"9","key":"10.1002\/14651858.CD003167.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1185\/030079906X121011","article-title":"Travoprost versus latanoprost combinations in glaucoma: economic evaluation based on visual field deficit progression","volume":"22","author":"Schmier","year":"2006","journal-title":"Current Medical Research & Opinion"},{"issue":"9","key":"10.1002\/14651858.CD003167.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1001\/archopht.124.9.1230","article-title":"Twice-daily 0.2% brimonidine-0.5% timolol fixed-combination therapy vs monotherapy with timolol or brimonidine in patients with glaucoma or ocular hypertension: a 12-month randomized trial","volume":"124","author":"Sherwood","year":"2006","journal-title":"Archives of Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD003167.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.ophtha.2006.03.025","article-title":"The safety and intraocular pressure-lowering efficacy of brimonidine tartrate 0.15% preserved with polyquaternium-1","volume":"113","author":"Whitson","year":"2006","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1002\/14651858.CD003167.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1001\/archopht.1980.01020041015002","article-title":"Biostatistical analysis of the collaborative glaucoma study. I. Summary report of the risk factors for glaucomatous visual-field defects","volume":"98","author":"Armaly","year":"1980","journal-title":"Archives of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD003167.pub3-BIB0060|cit60","first-page":"578","article-title":"The treatment of normal-tension glaucoma","volume":"126","author":"Caprioli","year":"1998","journal-title":"American Journal of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD003167.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0002-9394(98)00272-4","article-title":"The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma","volume":"126","author":"Collaborative Normal Tension Glaucoma Study Group","year":"1998","journal-title":"American Journal of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD003167.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1136\/bjo.82.2.146","article-title":"Randomised, controlled trial of spirometric changes in elderly people receiving timolol or betaxolol as initial treatment for glaucoma","volume":"82","author":"Diggory","year":"1998","journal-title":"British Journal of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD003167.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1001\/archopht.123.1.35","article-title":"Bronchial reactivity in healthy individuals undergoing long-term topical treatment with beta-blockers","volume":"123","author":"Gandolfi","year":"2005","journal-title":"Archives of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD003167.pub3-BIB0064|cit64","first-page":"130","article-title":"How to identify randomized controlled trials in MEDLINE: ten years on","volume":"94","author":"Glanville","year":"2006","journal-title":"Journal of the Medical Library Association"},{"key":"10.1002\/14651858.CD003167.pub3-BIB0065|cit65","unstructured":"Higgins JPT Green S Assessment of study quality. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006; Section 6] In: The Cochrane Library, Issue 4, 2006. Chichester, UK: John Wiley & Sons, Ltd"},{"key":"10.1002\/14651858.CD003167.pub3-BIB0066|cit66","unstructured":"Higgins JPT Green S Collecting data. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006; Section 7] In: The Cochrane Library, Issue 4, 2006. Chichester, UK: John Wiley & Sons, Ltd"},{"issue":"7509","key":"10.1002\/14651858.CD003167.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/bmj.38506.594977.E0","article-title":"Treatment of ocular hypertension and open angle glaucoma: meta-analysis of randomized controlled trials","volume":"331","author":"Maier","year":"2005","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD003167.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1023\/A:1007324907818","article-title":"Does medical treatment of mild intraocular hypertension prevent glaucoma?","volume":"13","author":"Aguinaga-Ontoso","year":"1997","journal-title":"European Journal of Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD003167.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0002-9394(83)90389-6","article-title":"Morphologic changes in the lamina cribrosa correlated with neural loss in open-angle glaucoma","volume":"95","author":"Quigley","year":"1983","journal-title":"American Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD003167.pub3-BIB0070|cit70","doi-asserted-by":"crossref","unstructured":"Quigley HA Miglior S Pfeiffer N Zeyen T Cunha-Vaz J Torri V European glaucoma prevention study. Authors' reply Ophthalmology 2005 1642 5","DOI":"10.1016\/j.ophtha.2005.05.024"},{"issue":"1","key":"10.1002\/14651858.CD003167.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1001\/archopht.1993.01090010100034","article-title":"Randomized clinical trials on medical treatment of glaucoma: are they appropriate to guide clinical practice?","volume":"111","author":"Rossetti","year":"1993","journal-title":"Archives of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD003167.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/bjo.74.4.196","article-title":"Biostatistical evidence for two distinct chronic open-angle glaucoma populations","volume":"74","author":"Schulzer","year":"1990","journal-title":"British Journal of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD003167.pub3-BIB0073|cit73","article-title":"Interventions for normal tension glaucoma","author":"Sycha","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD003167.pub3-BIB0074|cit74","first-page":"814","article-title":"Reproducibility of photogrammetric optic disc cup measurements","volume":"26","author":"Takamoto","year":"1985","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"7","key":"10.1002\/14651858.CD003167.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/bjo.84.7.710","article-title":"Effects of glaucoma medications on the cardiorespiratory and intraocular pressure status of newly diagnosed glaucoma patients","volume":"84","author":"Waldock","year":"2000","journal-title":"British Journal of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD003167.pub3-BIB0076|cit76","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002003.pub5","article-title":"Beta-blockers for hypertension","author":"Wiysonge","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD003167.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:03:36Z","timestamp":1787529816000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD003167.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Eyes and Vision Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2007,10,17]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2009,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003167.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,17]]}}}